He J - Search Results

1

Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments (SMART-CAT) in first-episode schizophrenia patients: Rationale and trial design.

Li X, Guo X, Fan X, Feng T, Wang C, Yao Z, Xu X, Chen Z, Wang H, Xie S, He J, Zhuo K, Xiang Q, Cen H, Wang J, Smith RC, Jin H, Keshavan MS, Marder SR, Davis JM, Jiang K, Xu Y, Liu D. Li X, et al. Among authors: he j. Schizophr Res. 2021 Apr;230:87-94. doi: 10.1016/j.schres.2020.11.010. Epub 2020 Dec 2. Schizophr Res. 2021. PMID: 33279374 Free article. Clinical Trial.

2

Prospects for development of group purchasing organizations (GPOs) in China within the context of national centralized drug procurement.

Chen M, Cong L, He J, Yang Y, Xu Y, Tang M, Jin C. Chen M, et al. Among authors: he j. Drug Discov Ther. 2020 Jul 15;14(3):145-148. doi: 10.5582/ddt.2020.03024. Epub 2020 Jun 12. Drug Discov Ther. 2020. PMID: 32536620 Free article. Review.

3

China issues the National Essential Medicines List (2018 edition): Background, differences from previous editions, and potential issues.

He J, Tang M, Ye Z, Jiang X, Chen D, Song P, Jin C. He J, et al. Biosci Trends. 2018;12(5):445-449. doi: 10.5582/bst.2018.01265. Biosci Trends. 2018. PMID: 30473550 Free article.

4

China has faster pace than Japan in population aging in next 25 years.

Chen R, Xu P, Song P, Wang M, He J. Chen R, et al. Among authors: he j. Biosci Trends. 2019 Sep 17;13(4):287-291. doi: 10.5582/bst.2019.01213. Epub 2019 Aug 21. Biosci Trends. 2019. PMID: 31434814 Free article.

5

A brief introduction to China's new Drug Administration Law and its impact on medications for rare diseases.

Wang Y, Chen D, He J. Wang Y, et al. Among authors: he j. Intractable Rare Dis Res. 2019 Nov;8(4):226-230. doi: 10.5582/irdr.2019.01133. Intractable Rare Dis Res. 2019. PMID: 31890448 Free PMC article. Review.

6

The impacts and unintended consequences of the nationwide pricing reform for drugs and medical services in the urban public hospitals in China.

Zhang X, Lai H, Zhang L, He J, Fu B, Jin C. Zhang X, et al. Among authors: he j. BMC Health Serv Res. 2020 Nov 23;20(1):1058. doi: 10.1186/s12913-020-05849-4. BMC Health Serv Res. 2020. PMID: 33225941 Free PMC article.

7

China has officially released its first national list of rare diseases.

He J, Kang Q, Hu J, Song P, Jin C. He J, et al. Intractable Rare Dis Res. 2018 May;7(2):145-147. doi: 10.5582/irdr.2018.01056. Intractable Rare Dis Res. 2018. PMID: 29862160 Free PMC article.

8

Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.

Wang X, Zhang X, He J. Wang X, et al. Among authors: he j. Biosci Trends. 2020 Mar 16;14(1):3-8. doi: 10.5582/bst.2020.01043. Epub 2020 Feb 17. Biosci Trends. 2020. PMID: 32062645 Free article.

9

The usage of enzyme replacement treatments, economic burden, and quality of life of patients with four lysosomal storage diseases in Shanghai, China.

Hu J, Zhu L, He J, Li D, Kang Q, Jin C. Hu J, et al. Among authors: he j. Intractable Rare Dis Res. 2021 Aug;10(3):190-197. doi: 10.5582/irdr.2021.01091. Intractable Rare Dis Res. 2021. PMID: 34466341 Free PMC article.

10

Accessibility of drugs for rare diseases in China: Policies and current situation.

Yang Y, Kang Q, Hu J, Kong F, Tang M, He J, Jin C. Yang Y, et al. Among authors: he j. Intractable Rare Dis Res. 2019 May;8(2):80-88. doi: 10.5582/irdr.2019.01068. Intractable Rare Dis Res. 2019. PMID: 31218157 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35,005 results

Search Page

Filters